ALGN vs RPRX · P/E 35, rev $2.10B vs P/E 15, rev $1.30B
Align Technology Inc (ALGN) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the ALGN and RPRX stock pages for the full models.
Not investment advice.